Datopotamab Deruxtecan-dlnk
Generic Name: datopotamab deruxtecan-dlnk
Manufactured by DAIICHI SANKYO INC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DATOPOTAMAB DERUXTECAN-DLNK (100MG). Application: BLA761464.
Overview
Manufactured by DAIICHI SANKYO INC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DATOPOTAMAB DERUXTECAN-DLNK (100MG). Application: BLA761464.
Dosage
Available as injectable for injection use.
Related Medications
Carbidopa Tablets
carbidopa tablets
Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
DESCRIPTION Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.3. It is designated chemically as (–)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Carbidopa tablets contain 25 mg of carbidopa. Inactive ingredients are microcrystalline cellulose, FD&C Yellow No.
Dhea (dehydroepiandrosterone)
dhea (dehydroepiandrosterone)
PURPOSE: DHEA (DEHYDROEPIANDROSTERONE) - Fatigue, Low Energy
Caffeine Citrate
caffeine citrate
DESCRIPTION CAFCIT® Injection (caffeine citrate injection, USP) for intravenous administration is a clear, colorless, sterile, non-pyrogenic, preservative-free, aqueous solution adjusted to pH 4.7. Each mL contains 20 mg caffeine citrate (equivalent to 10 mg of caffeine base) prepared in solution by the addition of 10 mg caffeine anhydrous to 5 mg citric acid monohydrate, 8.3 mg sodium citrate dihydrate and Water for Injection, USP.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.